Position
BRAIDWELL LP in Acadia Pharmaceuticals Inc
Back to the book · All holders of ACAD
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$9.04M$26.71 → $22.26
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 2.03M | $54.3M | — | — | — | 1.7% |
| Q1 2026 | 2.47M | $55M | $22.26 | −$9.04M | $9.78M | 1.8% |